Feenstra; Roelof W.

Patent Applications and Registrations

Patent applications and USPTO patent grants for Feenstra; Roelof W..The latest application filed is for "selective inhibitors of neurotensin degrading enzymes".

Company Profile

0.8.16

Feenstra; Roelof W. - Weesp NL
Feenstra, Roelof W - Weesp NL
Feenstra, Roelof W - Weeso NL

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Phenylpiperazine derivatives with a combination of partial dopamine-D.sub.2 receptor agonism and serotonin reuptake inhibition Grant 8,101,619 - Feenstra , et al. January 24, 2	2012-01-24
N-oxides as prodrugs of piperazine and piperidine derivatives Grant 7,750,013 - Koopman , et al. July 6, 2	2010-07-06
[1,2,4]-dithiazoli(di)ne derivatives, inducers of gluthathione-S-transferase and NADPH quinone oxido-reductase, for prophylaxis and treatment of adverse conditions associated with cytotoxicity in general and apoptosis in particular Grant 7,678,789 - Feenstra , et al. March 16, 2	2010-03-16
Selective inhibitors of neurotensin degrading enzymes App 20080146524 - Smid; Pieter ; et al.	2008-06-19
2-substituted-6-trifluoromethyl purine derivatives with adenosine-A.sub.3 antagonistic activity Grant 7,371,737 - Koch , et al. May 13, 2	2008-05-13
Piperazine and piperidine compounds Grant 7,297,699 - Feenstra , et al. November 20, 2	2007-11-20
Phenypiperazine Derivatives With A Combination Of Partial Dopamine-d2 Receptor Agonism And Serotonin Reuptake Inhibition App 20070142397 - Feenstra; Roelof W. ; et al.	2007-06-21
Neurotensin active 2,3,diaryl-pyrazolidine derivatives Grant 7,186,741 - Feenstra , et al. March 6, 2	2007-03-06
N-oxides as prodrugs of piperazine and piperidine derivatives App 20070043059 - Koopman; Theodorus S.M. ; et al.	2007-02-22
Phenylpiperazine derivatives with a combination of partial dopamine-D2 receptor agonism and serotonin reuptake inhibition App 20060247256 - Feenstra; Roelof W. ; et al.	2006-11-02
[1,2,4]-Dithiazoli(di)ne derivatives, inducers of gluthathione-S-transferase and NADPH quinone oxido-reductase, for prophylaxis and treatment of adverse conditions associated with cytotoxicity in general and apoptosis in particular App 20060194846 - Feenstra; Roelof W. ; et al.	2006-08-31
Anethole dithiolethione and other dithiolethiones for the treatment of conditions associated with dysfunction of monoamine neruotransmission App 20060194971 - Drukarch; Benjamin ; et al.	2006-08-31
Phenylpiperazine derivatives with a combination of partial dopamine-D2 receptor agonism and serotonin reuptake inhibition App 20060122190 - Feenstra; Roelof W. ; et al.	2006-06-08
Aryloxyethylamine and phenylpiperazine derivatives with a combination of partial dopamine-D2 receptor agonism and serotonin reuptake inhibition App 20060122247 - Feenstra; Roelof W. ; et al.	2006-06-08
Phenylpiperazine derivatives with a combination of partial dopamine-D2 receptor agonism and serotonin reuptake inhibition App 20060122189 - Feenstra; Roelof W. ; et al.	2006-06-08
New piperazine and piperidine compounds App 20060089366 - Feenstra; Roelof W. ; et al.	2006-04-27
2-Substituted-6-trifluoromethyl purine derivatives with adenosine-A3 antagonistic activity App 20060052331 - Koch; Melle ; et al.	2006-03-09
Piperazine and piperidine compounds Grant 6,911,448 - Feenstra , et al. June 28, 2	2005-06-28
Partial dopamine-D 2 receptor agonist plus serotonin and/oder noradrenaline inhibitor activity App 20050038015 - Bronzova, Juliana B ; et al.	2005-02-17
Phenylpiperazines Grant 6,828,325 - Feenstra , et al. December 7, 2	2004-12-07
Neurotensin active 2,3,diaryl-pyrazolidine derivatives App 20040242493 - Feenstra, Roelof W. ; et al.	2004-12-02
Use of compounds having combined dopamine d2, 5-ht1a and alpha adrenoreceptor agonistic action for treating cns disorders App 20030186838 - Feenstra, Roelof W. ; et al.	2003-10-02
Phenylpiperazines App 20030162791 - Feenstra, Roelof W ; et al.	2003-08-28
Piperazine and piperidine compounds App 20030119849 - Feenstra, Roelof W. ; et al.	2003-06-26

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.